Par, Sandoz buy 18 drugs as Watson-Actavis deal wins FTC nod

Watson Pharmaceuticals ($WPI) and Actavis won Federal Trade Commission approval for their $5.6 billion merger. Provided, that is, that they sell off a basketful of marketed and as-yet-unapproved products, and give up marketing rights to three …